5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence-Reference-Cited by-同舟云学术

5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence

Published:2017 Issue:2 Volume:8 Page:99
ISSN:2150-5349
Container-title:World Journal of Gastrointestinal Pharmacology and Therapeutics
language:en
Short-container-title:WJGPT

Author:

Gordon Morris

Publisher

Baishideng Publishing Group Inc.

Reference21 articles.

1. Svartz N. Salazyoprin, a new sulfanilamide preparation: A. Therapeutic results in rheumatic polyarthritis. B. Therapeutic results in ulcerative colitis. C. Toxic manifestations in treatment with sulfanilamide preparation. Acta Med Scand 1942;110:557-590.

2. The Medical Review Article: State of the Science

3. Oxman AD, Guyatt GH. Guidelines for reading literature reviews. Can Med Assoc J 1988;138:697-703.

4. Cochrane Library. Cochrane Collaboration handbook. Issue 4 Oxford: Update Software; 1997;.

5. Cochrane Collaboration. What is Cochrane evidence and how can it help you? Available from: http://www.cochrane.org/what-is-cochrane-evidence.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintaining remission in Crohn’s disease post surgery: what can we learn from Cochrane?;Frontline Gastroenterology;2024-01-17

2. Drug‐Related Adverse Reactions in Pediatric Inflammatory Bowel Disease;The Journal of Clinical Pharmacology;2023-09-09

3. Evaluation of a downstaging, bidirectional version of the Montreal classification of Crohn's disease: Analysis of 5‐year follow‐up data from the prospective BioCrohn study;Alimentary Pharmacology & Therapeutics;2023-04-13

4. Therapeutic Targeting of Intestinal Fibrosis in Crohn’s Disease;Cells;2022-01-26

5. Fibrostenotic strictures in Crohn’s disease;Intestinal Research;2020-10-31